Vir Biotechnology (VIR) Interest & Investment Income (2018 - 2026)

Vir Biotechnology (VIR) has 9 years of Interest & Investment Income data on file, last reported at $7.2 million in Q1 2026.

• For the quarter ending Q1 2026, Interest & Investment Income fell 41.5% year-over-year to $7.2 million; the trailing twelve-month figure through Mar 2026 stood at $35.1 million (down 44.06% YoY), and the FY2025 full-year result was $40.2 million, down 43.97% from the prior year.
• Interest & Investment Income declined to $7.2 million in Q1 2026, from $7.8 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $23.0 million in Q2 2023 to a low of $388000.0 in Q1 2022.
• A 5-year average of $13.8 million and a median of $14.2 million in 2024 frame the typical range for Interest & Investment Income.
• Across the five-year window, Interest & Investment Income surged 84736.36% in 2022 and plunged 46.58% in 2025, its largest moves.
• Tracing VIR's Interest & Investment Income over 5 years: stood at $16.2 million in 2022, then climbed by 28.22% to $20.7 million in 2023, then tumbled by 31.75% to $14.2 million in 2024, then slumped by 44.87% to $7.8 million in 2025, then decreased by 7.86% to $7.2 million in 2026.
• Business Quant data shows VIR's Interest & Investment Income at $7.2 million in Q1 2026, $7.8 million in Q4 2025, and $9.4 million in Q3 2025.